Influence of parental history of hypertension on blood pressure.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 10482973)

Published in J Hum Hypertens on September 01, 1999

Authors

V Lascaux-Lefebvre1, J Ruidavets, D Arveiler, P Amouyel, B Haas, D Cottel, A Bingham, P Ducimetière, J Ferrières

Author Affiliations

1: Département d'Epidémiologie, INSERM-518, Faculté de médecine, Toulouse, France.

Articles by these authors

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation (1994) 12.24

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet (1999) 10.46

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (1992) 5.56

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Predicting sudden death in the population: the Paris Prospective Study I. Circulation (1999) 3.80

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55

Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation (2001) 3.12

Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet (1999) 3.02

Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet (1994) 2.99

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet (1996) 2.82

BRCA-associated breast cancer in young women. J Clin Oncol (1998) 2.78

Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J Virol (1990) 2.75

Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 2.70

Correlation between structure and pathogenicity of potato spindle tuber viroid (PSTV). EMBO J (1985) 2.63

Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation (1999) 2.56

Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension (1996) 2.44

APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31

Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med (2000) 2.28

Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25

Unhealthy effects of atmospheric temperature and pressure on the occurrence of myocardial infarction and coronary deaths. A 10-year survey: the Lille-World Health Organization MONICA project (Monitoring trends and determinants in cardiovascular disease). Circulation (1999) 2.19

Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation (1994) 2.18

Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J (2004) 2.18

Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17

Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study. J Am Coll Cardiol (1999) 2.13

Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology (2006) 2.11

Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. QJM (1995) 2.09

The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08

Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 2.06

The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol (1998) 2.04

RNA-directed RNA polymerase from tomato leaves. II. Catalytic in vitro properties. J Biol Chem (1993) 2.03

Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993. Heart (2000) 1.97

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia (1989) 1.96

Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet (1999) 1.95

Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care (2001) 1.88

RNA-directed RNA polymerase from tomato leaves. I. Purification and physical properties. J Biol Chem (1993) 1.86

Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85

High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry (2012) 1.84

Transcription initiation at the Escherichia coli galactose operon promoters in the absence of the normal -35 region sequences. J Biol Chem (1986) 1.76

Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr (1998) 1.74

Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73

Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry (2008) 1.71

Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70

Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology (1999) 1.67

Association of occurrence of aneurysmal bleeding with meteorologic variations in the north of France. Stroke (1994) 1.65

Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology (2007) 1.64

Identification and characterization of the virus causing rabbit hemorrhagic disease. J Virol (1990) 1.64

Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl (1985) 1.63

Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas (2009) 1.61

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry (2011) 1.59

The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J (2002) 1.58

An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health (2008) 1.57

Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology (2011) 1.57

Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol (2000) 1.57

D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55

Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet (1998) 1.53

Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord (2001) 1.53

Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation (2004) 1.52

Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2005) 1.52

Purification and properties of an intranuclear virus-specific antigen from tissue infected with Borna disease virus. J Gen Virol (1986) 1.51

Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest (2001) 1.51

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51

New polymorphisms in the interleukin-10 gene--relationships to myocardial infarction. Eur J Clin Invest (2001) 1.50

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology (2005) 1.50

Sex differences in awareness and control of hypertension in France. J Hypertens (1997) 1.49

Anogenital warts in prepubertal children; sexual abuse or not? Int J STD AIDS (1993) 1.49

Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations. Am J Hum Genet (1997) 1.47

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest (1995) 1.46